Printer Friendly

SMITHKLINE BEECHAM ACQUIRES CORSODYL FROM ICI

 PHILADELPHIA, Nov. 19 ~PRNewswire~ -- SmithKline Beecham (NYSE: SBH) Consumer Brands announced today its acquisition from ICI of the worldwide Corsodyl business, the treatment for gingivitis, a gum disease, together with the rights to new polymer technology with oral hygiene applications.
 An oral antiseptic containing chlorhexidine, Corsodyl inhibits the formation of dental plaque and is used both to treat and prevent gingivitis. Corsodyl, is also used pre-operatively to control cross- infection and help gums heal following surgery.
 Corsodyl is available as a mouthwash, representing approximately 90 percent of the business. It is also available as a dental gel and in a spray form.
 Corsodyl is a unique brand in the United Kingdom. The product is also sold in Belgium, Holland, Scandinavia, South Africa and Spain where it is the brand leader, and is also available in Germany, France, Italy, Switzerland and Middle and Far Eastern markets.
 Peter Jensen, chairman of SmithKline Beecham Consumer Brands Europe, said: "Gingivitis affects 90 percent of the population at some time. It is particularly common among the elderly and, in an era were an increasing number of people are keeping their own teeth for life, Corsodyl will provide a vehicle to enhance oral care for these sufferers.
 "SmithKline Beecham Consumer Brands expects Corsodyl sales to grow through pharmacies, where it will be supported by the strength of SmithKline Beecham's health and personal care sales forces.
 "SmithKline Beecham is also an emerging presence in dental surgeries where specialized dental detailing forces promote its oral health products and antibiotics."
 SmithKline Beecham Brands has a strategic commitment to long-term development of oral care products, including therapeutic toothpastes, mouthwashes and toothbrushes.
 In the U.K. market SmithKline Beecham Consumer Brands is a leader in toothpastes with brands such as Aquafresh and Macleans. Its Odol range of oral health products is market leader in Germany, and Synthol is the leading mouthwash product in France. SmithKline Beecham Consumer Brands oral care business is also significant in many other worldwide markets.
 SmithKline Beecham -- one of the world's leading healthcare companies -- discovers, develops, manufactures and markets human and animal pharmaceuticals, over-the-counter medicines and clinical laboratory testing services.
 The sale of Corsodyl is in line with ICI Pharmaceuticals' strategy to concentrate on its core business of prescription only medicines. ICI Pharmaceuticals is a world leader in the treatment of cardiovascular disease, where it ranks number three in the world market, and in cancer, where it ranks number two worldwide.
 The value of the agreement between ICI and SmithKline Beecham is immaterial to both companies' net assets.
 ~delval~
 -0- 11~19~92
 ~CONTACT: Jeremy Heymsfeld, 215-751-5166, or Richard Williams (financial), 215-751-7002, both of SmithKline Beecham~
 (SBH)


CO: SmithKline Beecham Consumer Brands; ICI Pharmaceuticals ST: Pennsylvania IN: MTC SU: TNM

MP -- PH005 -- 2705 11~19~92 09:04 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 19, 1992
Words:462
Previous Article:NATIONWIDE PROPANE SUPPLIES ARE IN GOOD SHAPE FOR WINTER
Next Article:WE CARE INC. ANNOUNCES THE HEART BEEP QUIT SMOKING PROGRAM; NEW PROGRAM COSTS LESS THAN A PACK OF CIGARETTES A DAY
Topics:


Related Articles
SMITHKLINE BEECHAM U.S. SELLS A-200 BRAND
KODAK TO SELL STERLING WINTHROP TO SMITHKLINE BEECHAM FOR $2.9 BILLION
KODAK COMPLETES STERLING WINTHROP SALE TO SMITHKLINE BEECHAM
BLOCK DRUG COMPANY TO ACQUIRE NATURE'S REMEDY(R) FROM SMITHKLINE BEECHAM CONSUMER HEALTHCARE
SMITHKLINE BEECHAM CONSUMER HEALTHCARE SELLS NATURE'S REMEDY(R) TO BLOCK DRUG COMPANY
SMITHKLINE BEECHAM CONSUMER HEALTHCARE SELLS SINE-OFF(R), TELDRIN(R) AND ORAFIX(R) TO HOGIL PHARMACEUTICAL CORP.
SMITHKLINE BEECHAM ACQUIRES GERMAN MANUFACTURER OF VITAMINS, MINERALS AND OTC PRODUCTS
SmithKline Beecham Makes Strategic Investment in Romania.
Proposed Merger of Glaxo Wellcome and SmithKline Beecham Creating the Global Leader in Pharmaceuticals.
Proposed Merger of Glaxo Wellcome and SmithKline Beecham Creating the Global Leader in Pharmaceuticals.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters